Dashboard
Manage Tickers

IBIOiBio, Inc.

NYSE ibioinc.com


$ 1.90 $ 0.06 (3.56 %)    

Tuesday, 14-May-2024 15:58:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 1.88
$ 1.86
$ 0.00 x 0
$ 1.90 x 500
$ 1.86 - $ 1.91
$ 1.02 - $ 20.20
143,407
na
6.98M
$ -3.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 02-09-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 09-27-2023 06-30-2023 10-K
5 05-15-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 10-11-2022 06-30-2022 10-K
9 05-12-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 09-28-2021 06-30-2021 10-K
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 11-16-2020 09-30-2020 10-Q
16 10-13-2020 06-30-2020 10-K
17 05-15-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-Q
19 11-14-2019 09-30-2019 10-Q
20 08-26-2019 06-30-2019 10-K
21 05-10-2019 03-31-2019 10-Q
22 02-13-2019 12-31-2018 10-Q
23 11-13-2018 09-30-2018 10-Q
24 09-18-2018 06-30-2018 10-K
25 05-11-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-Q
27 11-09-2017 09-30-2017 10-Q
28 09-15-2017 06-30-2017 10-K
29 05-15-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-Q
31 11-18-2016 09-30-2016 10-Q
32 10-13-2016 06-30-2016 10-K
33 05-23-2016 03-31-2016 10-Q
34 02-22-2016 12-31-2015 10-Q
35 11-13-2015 09-30-2015 10-Q
36 10-13-2015 06-30-2015 10-K
37 05-15-2015 03-31-2015 10-Q
38 02-23-2015 12-31-2014 10-Q
39 11-14-2014 09-30-2014 10-Q
40 09-29-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ibio-q3-eps-071-up-from-953-yoy
iBio Q3 EPS $(0.71) Up From $(9.53) YoY
05/13/2024 20:13:01

iBio (AMEX:IBIO) reported quarterly losses of $(0.71) per share. This is a 92.55 percent increase over losses of $(9.53) per sh...

ibio-files-prospectus-relates-to-resale-from-time-to-time-of-up-to-106m-shares-of-common-stock-by-selling-stockholders
iBio Files Prospectus Relates To Resale Fr...
04/16/2024 20:14:47

-SEC Filing

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/29/2024 12:06:18

micro-cap-stock-ibio-doubles-on-wednesday---heres-why
Micro-Cap Stock iBio Doubles On Wednesday ...
03/27/2024 14:04:29

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares ...

Core News & Articles
Market-Moving News for March 27th
03/27/2024 12:31:22

IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for ob...

ibio-and-astralbio-announce-transformative-ai-drug-discovery-collaboration-to-rapidly-develop-novel-antibodies-for-obesity-and-cardiometabolic-diseases
iBio and AstralBio Announce Transformative...
03/27/2024 11:06:53

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") announces today that it has entered into a collaboration agre...

reported-earlier-ibio-raises-15m-in-equity-financing-shares-set-at-285-each
Reported Earlier, iBio Raises $15M In Equi...
03/27/2024 06:28:37

iBio, Inc.  an AI-driven innovator of precision antibody immunotherapies, announces today that it has entered into a securities...

otsuka-pharmaceutical-acquired-ibios-assets-related-to-its-early-stage-programmed-cell-death-protein-1-agonist-program-ibio-will-receive-an-upfront-payment-of-1m-and-is-eligible-to-receive-additional-contingent-cash-payments-of-up-to-525m
Otsuka Pharmaceutical Acquired iBio's Asse...
02/26/2024 12:48:06

top-4-health-care-stocks-that-may-rocket-higher-in-q1
Top 4 Health Care Stocks That May Rocket H...
01/16/2024 11:50:17

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

ibios-subsidiary-ibio-cdmo-and-woodforest-national-bank-have-amended-the-credit-agreement-dated-november-1-2021-extending-the-maturity-date-from-december-31-2023-to-the-earlier-march-29-2024-or-the-acceleration-of-maturity-of-the-term-loan-followin
iBio's Subsidiary, iBio CDMO And Woodfores...
12/26/2023 12:25:31

looking-into-ibios-recent-short-interest
Looking Into iBio's Recent Short Interest
12/08/2023 14:15:22

crude-oil-moves-lower-autozone-profit-tops-views
Crude Oil Moves Lower; AutoZone Profit Top...
12/05/2023 19:27:49

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0...

why-daktronics-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Daktronics Shares Are Trading Lower By...
12/05/2023 18:06:18

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 17:31:07

dow-falls-100-points-ism-services-pmi-increases-in-november
Dow Falls 100 Points; ISM Services PMI Inc...
12/05/2023 17:11:48

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded...

us-stocks-down-jm-smucker-posts-upbeat-earnings
US Stocks Down; JM Smucker Posts Upbeat Ea...
12/05/2023 14:39:45

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market openi...

why-gitlab-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket
Why GitLab Shares Are Trading Higher By Ov...
12/05/2023 14:04:20

Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results ...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 13:07:35

ibio-inc-announces-pricing-of-45m-public-offering
iBio, Inc. Announces Pricing Of $4.5M Publ...
12/05/2023 13:02:59

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), today announced the pricing of its reasonable best efforts p...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/04/2023 21:31:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION